FDA Seeks Public Input on Regulating Generative AI Medical Devices

In one line: The US FDA has launched a public comment process to decide how to regulate medical devices powered by generative AI.

Key points

• The FDA is reported to be formally requesting input from the public and industry on how to oversee generative AI–based medical devices.
• Unlike static software devices, generative AI can produce and alter its own outputs over time, so its performance may shift after deployment — prompting discussion of new oversight approaches.
• Feedback gathered is expected to inform future approval and monitoring standards.

Why it matters

As generative AI moves quickly into diagnostics and clinical settings, a regulatory gap affects both patient safety and time-to-market. The FDA's move signals the shape of the rules that medical AI companies will need to prepare for.

Read more

• FDA seeks public feedback on regulating generative AI medical devices — Today's Medical Developments